Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Wedbush Upgrades National Health Investors to Outperform, Raises Price Target to $64

Author: Benzinga Newsdesk | February 26, 2024 02:37pm
Wedbush analyst Richard Anderson upgrades National Health Investors (NYSE:NHI) from Neutral to Outperform and raises the price target from $57 to $64.

Posted In: NHI


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist